BIEL Crystal recognized as "TopBrand 2025 China Brand 500"

Friday, Aug 15, 2025 2:23 am ET1min read

BIEL Crystal, a major supplier to Apple, has been recognized among "TopBrand 2025 China Brand 500" at the 19th China Brand Festival. This accolade highlights BIEL Crystal's extensive market influence and innovative brand strategy. The company operates 9 advanced manufacturing bases worldwide and produces 2.2 billion pieces annually, earning broad market recognition. BIEL Crystal integrated technological innovation with brand building by launching its proprietary technology brand: "Witch Cloak" ultra-hard coating.

SHENZHEN, China, Aug. 15, 2025 /PRNewswire/ -- BIEL Crystal, a major supplier to Apple, has been recognized among "TopBrand 2025 China Brand 500" at the 19th China Brand Festival. This accolade highlights BIEL Crystal's extensive market influence and innovative brand strategy. The company operates 9 advanced manufacturing bases worldwide and produces 2.2 billion pieces annually, earning broad market recognition [1].

BIEL Crystal, a global leader in smart device exterior structures, has integrated technological innovation with brand building by launching its proprietary technology brand: "Witch Cloak" ultra-hard coating. First applied in HONOR's flagship foldable smartphone Magic V5, this innovation delivers enhanced protection and superior visual experiences, generating significant impact across the smart terminal industry [2].

The China Brand Festival recognition solidifies BIEL Crystal's extensive brand influence and its leadership position within the global smart device exterior structure sector. This achievement underscores the company's commitment to innovation and its strategic importance in the tech industry.

References:
[1] https://www.prnewswire.com/news-releases/biel-crystal-scoring-china-topbrand-500-at-china-brand-festival-302530869.html
[2] https://www.streetinsider.com/PRNewswire/BIEL+Crystal+scoring+China+TopBrand+500+at+China+Brand+Festival/25209891.html

Comments



Add a public comment...
No comments

No comments yet